{"id":"W2900778417","doi":"10.1093/annonc/mdy425","title":"Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"William Osler Health System; University of Toronto","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Gefitinib; Erlotinib; Oncology; Discontinuation; Hazard ratio; Lung cancer; Progression-free survival; Erlotinib Hydrochloride; Ceritinib; T790M; Chemotherapy; Cancer; Epidermal growth factor receptor; Confidence interval; Crizotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009632523,0.000321726,0.0008019827,0.0003421688,0.000251523,0.0009275984,0.0003918452,0.0006774489,0.002743731],"category_scores_gemma":[0.001585987,0.0001219275,0.002569747,0.0004067877,0.0002817487,0.0009359109,0.0005794115,0.001359293,0.000271338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001090081,"about_ca_system_score_gemma":0.0007502972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002171457,"about_ca_topic_score_gemma":0.00606927,"domain_scores_codex":[0.9995151,0.0001049797,0.00003764972,0.00008244115,0.00005922438,0.000200635],"domain_scores_gemma":[0.9991805,0.0001946509,0.0002896882,0.0000349108,0.00004546272,0.0002547429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2881377,0.002771805,0.5531555,0.0009364117,0.005208319,0.0006305998,0.0003212877,0.003572373,0.002428196,0.0008344702,0.008454041,0.1335494],"study_design_scores_gemma":[0.01073556,0.06855859,0.9015695,0.0003362667,0.005521273,0.001057431,0.0007890781,0.003490522,0.001489349,0.001594749,0.004775567,0.00008222539],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941041,0.002211296,0.00005793073,0.0003835389,0.00007901951,0.0000385168,0.001155221,0.000008774922,0.001961603],"genre_scores_gemma":[0.9972619,0.0005196916,0.00004841465,0.0001779039,0.00009704659,0.00002462771,0.001298413,0.000002212747,0.0005697499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002743731,"threshold_uncertainty_score":0.009178638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02403826421624572,"score_gpt":0.4144345232529033,"score_spread":0.3903962590366576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}